Intersect ENT of Menlo Park, California has received FDA approval for its PROPEL Contour steroid releasing sinus implant, which is indicated for treatment of chronic sinusitis in the frontal and maxillary sinuses. Besides providing structural integrity, it reduces the need for orally administered steroids and only supplies them where needed.
The PR (Read more...)